Belite Bio BLTE
NASDAQ BLTE
$169.82 +3.16 (+1.90%)
At close: Sep 30, 2026 · 4:00 PM EDT

Belite Bio (BLTE) Cash from Operations (2020 - 2025)

Updated

Belite Bio (BLTE) recorded Cash from Operations of -$10.39 million in Q4 2025, compared with -$4.6 million a year earlier.

Analysis

Belite Bio (BLTE) Cash from Operations (2020 - 2025) Analysis & Trends

For FY2025, Belite Bio reported Cash from Operations of -$36.99 million.

  • Across earlier years, Cash from Operations came in at -$29.23 million in FY2024, -$29.84 million in FY2023, -$11.46 million in FY2022 and -$7.47 million in FY2021.
  • The Q4 2025 figure is the lowest quarterly Cash from Operations since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 8.62 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 3.44 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 4.58 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 3.57 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.13 Bn
10 Belite Bio 6.56 Bn 6.56 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -10.39 Mn
Dec 31, 2024 -4.60 Mn
Dec 31, 2022 -11.46 Mn
Dec 31, 2021 -7.47 Mn
Dec 31, 2020 -4.44 Mn
API Access

Belite Bio Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BLTE&period=max&api_key=YOUR_API_KEY